ANDA

(redirected from abbreviated new drug application)
Also found in: Medical, Encyclopedia.
AcronymDefinition
ANDAAbbreviated New Drug Application (US FDA)
ANDAAsociacion Nacional de Acuaductos y Alcantarillados (Spanish: National Association of Aqueducts and Sewer; El Salvador)
ANDAAsociación Nacional de Actores (México)
ANDAAssociation Nationale pour le Développement Agricole (French: National Association for Agricultural Development)
ANDAAsociación Nacional de Derecho Ambiental
ANDAAssociation of National Dance Agencies
ANDAArkansas Negro Democratic Association
ANDAActive Non-Destructive Analysis
ANDAAustrian National Defense Academy (German, Landesverteidigungsakademie, Austria)
References in periodicals archive ?
The company added that the Abbreviated New Drug Application (ANDA) for Diazepam Oral Solution, 5 mg/5 ml is the therapeutic equivalent to the reference listed drug, Diazepam Oral Solution, 5 mg/5 ml, of Roxane Laboratories.
Lannett passes US FDA approval for Diazepam Oral Solution, 5 mg/5 ml
The United States Food and Drug Administration has approved an Abbreviated New Drug Application for ANI Pharmaceuticals' (NASDAQ:ANIP) Oxycodone HCl Capsules, 5 mg, it was reported yesterday.
US Food and Drug Administration approves Abbreviated New Drug Application for ANI Pharmaceuticals' Oxycodone HCl Capsules 5mg
The company said the Abbreviated New Drug Application (ANDA) for Memantine Hydrochloride Oral Solution 2 mg/ml is the therapeutic equivalent to the reference listed drug Namenda Oral Solution, 2 mg/ml of Forest Pharmaceuticals.
Lannett passes US FDA approval for Memantine Hydrochloride Oral Solution, 2 mg/ml to treat dementia associated with Alzheimer's disease
Actavis plc (NYSE: ACT), an Ireland-based global pharmaceutical company, announced on Friday that it has filed an Abbreviated New Drug Application seeking approval with the US Food and Drug Administration to market Ambrisentan Tablets, five mg and 10 mg.
Actavis files Abbreviated New Drug Application seeking approval for Ambrisentan Tablets
M2 EQUITYBITES-March 16, 2015-Breckenridge Pharmaceutical files abbreviated new drug application with Paragraph IV certification for generic version of Boehringer Ingelheim's Pradaxa
Breckenridge Pharmaceutical files abbreviated new drug application with Paragraph IV certification for generic version of Boehringer Ingelheim's Pradaxa
M2 PHARMA-March 16, 2015-Breckenridge Pharmaceutical files abbreviated new drug application with Paragraph IV certification for generic version of Boehringer Ingelheim's Pradaxa
Breckenridge Pharmaceutical files abbreviated new drug application with Paragraph IV certification for generic version of Boehringer Ingelheim's Pradaxa
It was reported yesterday that the company has launched the product after receiving final approval for its abbreviated new drug application from the United States Food and Drug Administration.
Breckenridge Pharmaceutical launches Mefenamic Acid 250mg Capsules
M2 EQUITYBITES-September 1, 2014-Momenta Pharmaceuticals's Copaxone receives abbreviated new drug application for Copaxone from US Food and Drug Administration
Momenta Pharmaceuticals's Copaxone receives abbreviated new drug application for Copaxone from US Food and Drug Administration
Acronyms browser ?
Full browser ?